Shanghai Xinzhi Medical Technology Co., Ltd. announced a private placement of common shares for the gross proceeds of CNY 15 million on April 14, 2023. The transaction will include participation from new investor Shanghai Bio-heart Biological Technology Co., Ltd. Post completion, Shanghai Bio-heart Biological Technology Co., Ltd. will hold 14.79% stake in exchange for CNY 361,144 of registered capital of the company.
Shanghai Bio-heart Biological Technology Co., Ltd.
Equities
2185
CNE100004JH3
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.04 HKD | -5.12% | -1.45% | -40.35% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.35% | 67.04M | |
+12.01% | 128B | |
-8.47% | 11.26B | |
+6.26% | 9.28B | |
+35.53% | 5.42B | |
+8.68% | 3.45B | |
-8.89% | 2.8B | |
-10.68% | 2.1B | |
-10.77% | 1.98B | |
-26.31% | 1.71B |
- Stock Market
- Equities
- 2185 Stock
- News Shanghai Bio-heart Biological Technology Co., Ltd.
- Shanghai Xinzhi Medical Technology Co., Ltd. announced that it expects to receive CNY 15 million in funding from Shanghai Bio-heart Biological Technology Co., Ltd.